daunorubicin has been researched along with Bone Cancer in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (51.85) | 18.7374 |
| 1990's | 6 (22.22) | 18.2507 |
| 2000's | 4 (14.81) | 29.6817 |
| 2010's | 3 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, WM; Hsieh, IS; Yang, RS | 1 |
| Adaletli, I; Aki, H; Apak, H; Bariş, S; Canbolat, A; Celkan, TT; Doğru, O; Hallac, M; Karaman, S; Kurugoglu, S; Ozdemir, N; Ozdil, M; Ozkan, A; Yildiz, I | 1 |
| Borges, JP; Dias, SJ; Ferreira, IM; Novo, CM; Soares, PI | 1 |
| Campbell, KJ; Perkins, ND; Rocha, S | 1 |
| Balcerska, A; Balwierz, W; Chełmecka-Hanuszewicz, L; Chybicka, A; Cwiklińska, M; Derwich, K; Jackowska, T; Kaczmarek-Kanold, M; Kowalczyk, JR; Kołtan, A; Matysiak, M; Odój, T; Płoszyńska, A; Sońta-Jakimczyk, D; Steczowicz, M; Wachowiak, J; Wojciechowska, V; Wójtowicz, A; Wysocki, M | 1 |
| Benini, S; Geroni, C; Hattinger, CM; Manara, MC; Mercuri, M; Pasello, M; Picci, P; Scotlandi, K; Serra, M; Stoico, G | 1 |
| Corona, G; Crivellari, D; Lestuzzi, C; Lombardi, D; Lucenti, A; Magri, MD; Massacesi, C; Sorio, R; Talamini, R; Toffoli, G; Veronesi, A | 1 |
| Bizer, VA; Timukhina, VN | 1 |
| Baker, LH; Benjamin, RS; Frank, J; Lane, M; Zidar, BL | 1 |
| Kiselev, AV; Syrkin, AB | 1 |
| Bizer, VA; Vatin, AE | 1 |
| Miller, DR; Mitta, SK; Steinherz, L; Tan, CT | 1 |
| Andolina, M; Arrighini, A; Barisone, E; Brach del Prever, A; Leone, L; Madon, E; Massara, FM; Miniero, R; Saroglia, EM; Soldano, S | 1 |
| Filippi, C; Garbe, L; Garnier, G; Gratecos, N; Michiels, JF; Pesce, A; Poitou, G; Rosenthal, E; Taillan, B; Vinti, H | 1 |
| Cleary, ML; Davis, RE; Kamel, OW; Soslow, RA; Warnke, RA | 1 |
| Krishan, A; KuKuruga, MA; Kunikane, H; Lucas, D; Ramachandran, C; Ryan, JR; Zalupski, MM | 1 |
| Beck-Bornholdt, HP; Carl, UM; Fröschle, G; Zieron, JO | 1 |
| Arbes, H; Kotz, R; Leber, H; Ramach, W; Wolf, A | 1 |
| Franz, Ch; Fuhrmann, U; Rieger, M | 1 |
| Broggini, M; Colombo, T; Donelli, MG; Garattini, S | 1 |
| Burchenal, J; D'angio, G; Exelby, P; Fang, S; Lieberman, P; Murphy, ML; Wollner, N | 1 |
| Armata, J; Balwierz, W; Skoczeń, S; Tacik, J | 1 |
| Brandi, M; De Lena, M; Logroscino, A; Lorusso, V; Maiello, E; Paradiso, A | 1 |
| Bozzi, D; Brandi, M; Calabrese, P; De Lena, M; Romito, S | 1 |
| Fromer, JL; Jaffe, N | 1 |
| Fernandez, CH; Gottlieb, JA | 1 |
| Schweisguth, O | 1 |
1 review(s) available for daunorubicin and Bone Cancer
| Article | Year |
|---|---|
Proceedings: Recent progress in the chemotherapy of primary tumors of bone.
Topics: Antineoplastic Agents; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Daunorubicin; Doxorubicin; Drug Therapy, Combination; Humans; Osteosarcoma; Sarcoma, Ewing; Vincristine | 1972 |
1 trial(s) available for daunorubicin and Bone Cancer
| Article | Year |
|---|---|
Innovative schedule of oral idarubicin in elderly patients with metastatic breast cancer: comprehensive results of a phase II multi-institutional study with pharmacokinetic drug monitoring.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Bone Neoplasms; Breast Neoplasms; Chromatography, High Pressure Liquid; Daunorubicin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Humans; Idarubicin; Liver Neoplasms; Lung Neoplasms; Soft Tissue Neoplasms | 2006 |
25 other study(ies) available for daunorubicin and Bone Cancer
| Article | Year |
|---|---|
Osteopontin upregulates the expression of glucose transporters in osteosarcoma cells.
Topics: Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Daunorubicin; Etoposide; Fluorouracil; Glucose Transport Proteins, Facilitative; Glucose Transporter Type 1; Glucose Transporter Type 3; Humans; Integrin alphaVbeta3; Membrane Transport Modulators; Methotrexate; Osteopontin; Osteosarcoma; Phloretin; Up-Regulation | 2014 |
Treatment of pediatric Burkitt lymphoma in Turkey.
Topics: Abdominal Neoplasms; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biopsy; Bone Neoplasms; Burkitt Lymphoma; Child; Child, Preschool; Daunorubicin; Disease-Free Survival; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Multivariate Analysis; Neoplasm Staging; Predictive Value of Tests; Prednisone; Risk Factors; Survival Analysis; Testicular Neoplasms; Turkey; Vincristine | 2010 |
Doxorubicin vs. ladirubicin: methods for improving osteosarcoma treatment.
Topics: Anthracyclines; Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Drug Carriers; Drug Resistance, Neoplasm; Humans; Osteosarcoma | 2012 |
Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cells, Cultured; Daunorubicin; DNA, Neoplasm; Doxorubicin; Fibroblasts; Gene Expression Regulation, Neoplastic; Genes, Reporter; Histone Deacetylases; Humans; Kinetics; Mice; NF-kappa B; Promoter Regions, Genetic; RNA, Messenger; Transcription Factor RelA; Transcription, Genetic; Transcriptional Activation; Tumor Necrosis Factor-alpha; Tumor Suppressor Proteins; Ultraviolet Rays | 2004 |
[Treatment results in children with standard-risk acute lymphoblastic leukemia. Report of the Polish Pediatric Leukemia/Lymphoma Study Group].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Bone Neoplasms; Central Nervous System Neoplasms; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Infant; Infant, Newborn; Male; Mercaptopurine; Methotrexate; Poland; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Remission Induction; Retrospective Studies; Risk Factors; Secondary Prevention; Survival Analysis; Testicular Neoplasms; Time Factors; Treatment Outcome; Vincristine | 2004 |
4-Demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548): a promising new candidate for chemotherapeutic treatment of osteosarcoma patients.
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Neoplasms; Cell Cycle; Cell Line, Tumor; Daunorubicin; Doxorubicin; Drug Interactions; Drug Screening Assays, Antitumor; Humans; Osteosarcoma | 2005 |
[Treatment results in osteogenic sarcoma in children and adolescents with the use of karminomycin].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carubicin; Child; Child, Preschool; Combined Modality Therapy; Daunorubicin; Drug Evaluation; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Melphalan; Osteosarcoma; Time Factors; Vincristine | 1984 |
Combination chemotherapy for advanced sarcomas of bone and mesothelioma utilizing rubidazone and DTIC: a Southwest Oncology Group Study.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Bone Neoplasms; Dacarbazine; Daunorubicin; Drug Therapy, Combination; Female; Humans; Male; Mesothelioma; Middle Aged; Sarcoma | 1983 |
Comparative toxicity of carminomycin, rubomycin and adriamycin in mice and experience with carminomycin in spontaneous tumors of dogs.
Topics: Animals; Bone Neoplasms; Carubicin; Daunorubicin; Dog Diseases; Dogs; Doxorubicin; Lethal Dose 50; Male; Mice; Osteosarcoma | 1980 |
[Changes in the T- and B-lymphocyte ratio in bone sarcoma patients before and after carminomycin treatment].
Topics: Adolescent; Adult; B-Lymphocytes; Bone Neoplasms; Carubicin; Child; Child, Preschool; Daunorubicin; Humans; Leukocyte Count; Osteosarcoma; Rosette Formation; Sarcoma, Ewing; T-Lymphocytes; Time Factors | 1980 |
Phase I trial of rubidazone (NSC 164011) in children with cancer.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Daunorubicin; Drug Evaluation; Female; Humans; Infant; Leukemia; Leukocyte Count; Lymphoma; Male; Neuroblastoma; Platelet Count; Remission, Spontaneous; Soft Tissue Neoplasms | 1981 |
[Use of cyclosporin and verapamil in association with chemotherapy in the treatment of pediatric patients with advanced-stage neoplasms. A pilot study].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cerebellar Neoplasms; Child; Child, Preschool; Cyclosporins; Daunorubicin; Doxorubicin; Drug Resistance; Female; Humans; Male; Medulloblastoma; Neoplasms; Neuroblastoma; Osteosarcoma; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Verapamil; Vincristine | 1994 |
Malignant fibrous histiocytoma following bone marrow transplantation for acute leukemia.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Bone Neoplasms; Combined Modality Therapy; Cytarabine; Daunorubicin; Graft vs Host Disease; Histiocytoma, Benign Fibrous; Humans; Leukemia, Myeloid, Acute; Male; Methotrexate; Radiography | 1993 |
True histiocytic lymphoma following therapy for lymphoblastic neoplasms.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; Fatal Outcome; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Mercaptopurine; Methotrexate; Methylprednisolone; Neoplasms, Second Primary; Neoplastic Stem Cells; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Remission Induction; Scapula; Spinal Neoplasms; Vincristine | 1996 |
Flow cytometric analysis of P-glycoprotein expression and drug efflux in human soft tissue and bone sarcomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antibodies; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Neoplasms; Child; Daunorubicin; Drug Resistance, Neoplasm; Female; Flow Cytometry; Histiocytoma, Benign Fibrous; Humans; Leiomyosarcoma; Leukocyte Common Antigens; Liposarcoma; Male; Middle Aged; Osteosarcoma; Predictive Value of Tests; Prognosis; Sarcoma; Soft Tissue Neoplasms | 1997 |
Combined modality treatment of bone metastases: response of the rhabdomyosarcoma R1H of the rat to postoperative irradiation combined with local release of daunorubicin from acrylic cement.
Topics: Animals; Antibiotics, Antineoplastic; Bone Cements; Bone Neoplasms; Chi-Square Distribution; Combined Modality Therapy; Confidence Intervals; Daunorubicin; Disease Models, Animal; Dose-Response Relationship, Radiation; Male; Multivariate Analysis; Neoplasm Transplantation; Postoperative Period; Rats; Rats, Inbred Strains; Rhabdomyosarcoma; Survival Rate; Treatment Outcome | 1998 |
[Clinical observations on the use of high-dose methotrexate treatment in osteogenic sarcoma (author's transl)].
Topics: Adolescent; Adult; Bleomycin; Bone Neoplasms; Child; Cyclophosphamide; Daunorubicin; Doxorubicin; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Osteosarcoma; Vincristine | 1977 |
[Cardiotoxicity in long term treatment with cytostatics (author's transl)].
Topics: Bone Neoplasms; Child; Daunorubicin; Doxorubicin; Facial Neoplasms; Female; Heart Failure; Humans; Humerus; Osteosarcoma; Rhabdomyosarcoma; Sacrum; Sarcoma, Ewing; Time Factors | 1978 |
Differential distribution of antitumor agents in primary and secondary tumors.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Carcinoma 256, Walker; Cyclophosphamide; Daunorubicin; Doxorubicin; Female; Hydroxyurea; Lung Neoplasms; Lymphatic Metastasis; Male; Mercaptopurine; Methotrexate; Methylnitrosourea; Mice; Neoplasm Metastasis; Neoplasms, Experimental; Rats; Sarcoma, Experimental | 1977 |
Non-Hodgkin's lymphoma in children: results of treatment with LSA2-L2 protocol.
Topics: Adolescent; Antineoplastic Agents; Asparaginase; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Therapy, Combination; Female; Humans; Hydroxyurea; Leukemia; Leukemia, Lymphoid; Lymph Nodes; Lymphoma; Male; Mediastinal Neoplasms; Methotrexate; Nasopharyngeal Neoplasms; Ovarian Neoplasms; Skin Neoplasms; Stomach Neoplasms; Thioguanine; Vincristine | 1975 |
[Disparity of the bone marrow involvement in a 5-year-old boy with primary non-Hodgkin's malignant lymphoma of the bone].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Bone Neoplasms; Child, Preschool; Daunorubicin; Humans; Lymphoma, Non-Hodgkin; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Radius; Vincristine | 1992 |
Intravenous administration of cyclophosphamide, methotrexate and 5-fluorouracil in metastatic breast cancer. A pilot study.
Topics: Administration, Oral; Bone Neoplasms; Breast Neoplasms; Daunorubicin; Drug Evaluation; Female; Humans; Idarubicin; Remission Induction; Soft Tissue Neoplasms | 1988 |
4-Demethoxydaunorubicin administered orally in advanced breast cancer. A phase II study.
Topics: Acute Kidney Injury; Administration, Oral; Adult; Aged; Bone Marrow Diseases; Bone Neoplasms; Breast Neoplasms; Daunorubicin; Female; Humans; Idarubicin; Middle Aged; Nausea; Soft Tissue Neoplasms; Stomach Ulcer; Vomiting | 1988 |
Urticaria pigmentosa and acute lymphoblastic leukemia.
Topics: Acute Disease; Asparaginase; Bone Marrow Examination; Bone Neoplasms; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Humans; Leukemia, Lymphoid; Male; Mercaptopurine; Methotrexate; Prednisone; Radiography; Remission, Spontaneous; Urticaria Pigmentosa; Vincristine | 1973 |
Treatment of neuroblastoma.
Topics: Age Factors; Bone Neoplasms; Catecholamines; Child, Preschool; Cyclophosphamide; Daunorubicin; Humans; Infant; Infant, Newborn; Lymphatic Metastasis; Male; Neoplasm Metastasis; Neoplasm Regression, Spontaneous; Neuroblastoma; Norepinephrine; Prognosis; Vincristine | 1968 |